Sept 26 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCED ON WEDNESDAY THE
PUBLICATION IN
SURGICAL ENDOSCOPY OF POSITIVE RESULTS FROM LARGE U.S.
PROSPECTIVE MULTI-CENTER CLINICAL TRIAL ON DETECTION OF
BARRETT’S ESOPHAGUS WITH CELLVIZIO®
* THERE WAS NO STATISTICALLY SIGNIFICANT DIFFERENCE IN
PERFORMANCE
BETWEEN NOVICE PCLE USERS AND EXPERT REVIEW.
* A BLINDED EXPERT REVIEW OF DISCREPANT RESULTS BETWEEN
CELLVIZIO
AND BIOPSIES CONFIRMED THAT INTESTINAL METAPLASIA DETECTED BY
CELLVIZIO WAS INDEED PRESENT IN 56 OF 61 PATIENTS WITH NEGATIVE
BIOPSIES
Source text for Eikon: ID:nBw4787XJa
Further company coverage: MKEA.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))